T&R Biofab Co Ltd is a Korea-based company mainly engaged in the production and sale of bioresorbable scaffolds. The bioresorbable scaffolds are sold under the name of T&R mesh and T&R Dental Mesh. In addition, the Company is involved in the production and sale of three Dimensions (3D) biodegradable polymer printing system, bioinks, 3D organoid and 3D cell therapies, among others. The bioinks are sold under the name of deCelluid. The Company distributes its products within the domestic market and to overseas markets.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
26-08-26	₩2,480.00	-1.00%	124,722
26-08-25	₩2,505.00	+3.09%	151,631
26-08-24	₩2,430.00	-0.82%	127,218
26-08-21	₩2,450.00	-2.39%	110,852
26-08-20	₩2,510.00	+4.37%	95,966

End-of-day quote Korea S.E.

More quotes

End-of-day quote Korea S.E. 2026-08-25			5-day change	1st Jan Change
2,505.00 ^KRW	+3.09%		+1.42%	-35.93%

01-20	T&R Biofab's Q4 2025 Sales Jump 500%; Shares Decline 5%	MT
24-09-22	T&R Biofab Co., Ltd.(KOSDAQ:A246710) dropped from S&P Global BMI Index	CI

Market Cap	118B 85.26M 73.17M 68.68M 62.73M 118M 8.13B 119M 813M 315M 4.1B 320M 313M 13.59B	P/E 2024	-12.2x	P/E 2025	-3.58x
Enterprise Value	140B 101M 86.61M 81.29M 74.25M 140M 9.62B 141M 962M 373M 4.86B 379M 371M 16.08B	EV / Sales 2024	25.1x	EV / Sales 2025	7.45x
Free-Float	78.94%	Yield 2024 *	-	Yield 2025	-

01-20	T&R Biofab's Q4 2025 Sales Jump 500%; Shares Decline 5%	MT
24-09-22	T&R Biofab Co., Ltd.(KOSDAQ:A246710) dropped from S&P Global BMI Index	CI
24-08-04	T&R Biofab Co., Ltd. announced that it has received KRW 7 billion in funding from BTC Investment	CI
24-07-22	T&R Biofab Co., Ltd. announced that it expects to receive KRW 7 billion in funding from BTC Investment and another investor	CI
24-07-03	T&R Biofab Co., Ltd. announced that it has received KRW 2.99999656 billion in funding from KB Securities Co.,Ltd, NH Investment & Securities Co., Ltd., Shinhan Bank, The Korea Securities Finance Corporation	CI
24-06-24	T&R Biofab Co., Ltd. announced that it expects to receive KRW 2.9999956 billion in funding from KB Securities Co.,Ltd, NH Investment & Securities Co., Ltd., Shinhan Bank, The Korea Securities Finance Corporation	CI
23-12-21	T&R Biofab Co., Ltd. announced that it has received KRW 1.999996 billion in funding from Korea Investment Partners Co. Ltd., DreamCIS, Inc.	CI
23-12-13	T&R Biofab Co., Ltd. announced that it expects to receive KRW 1.999996 billion in funding from Korea Investment Partners Co. Ltd., DreamCIS, Inc.	CI
23-10-18	CJ Foods Partners with T&R Biofab to Shape the Future of Food	CI
23-08-03	T&R Biofab Co., Ltd. announced that it has received KRW 24 billion in funding	CI
23-07-25	T&R Biofab Co., Ltd. announced that it expects to receive KRW 24 billion in funding	CI
23-05-14	T&R Biofab Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
21-09-20	T&R Biofab Co., Ltd.(KOSDAQ:A246710) added to S&P Global BMI Index	CI

1 day	+3.09%
1 week	+1.42%
Current month	-16.50%
1 month	+7.05%
3 months	+8.91%
6 months	-26.65%
Current year	-35.93%

T&R Biofab Co., Ltd. Stock

Stocks

A246710

KR7246710008

Medical Equipment, Supplies & Distribution

Valuation: T&R Biofab Co., Ltd.

Chart: T&R Biofab Co., Ltd.

Latest news : T&R Biofab Co., Ltd.

Quotes and Performance

Price Extremes

Managers and Directors: T&R Biofab Co., Ltd.

Latest insider transactions

Medical Devices & Implants

Financials

Company Profile

Quotes

1 week	2,365	2,550
1 month	2,265	3,265
Current year	1,777	4,800
1 year	1,127	4,925
3 years	1,127	11,575
5 years	1,127	36,333.33
10 years	1,127	37,916.67

Manager	Title	Age	Since
Won-Soo Yoon CEO	Chief Executive Officer	56	-
Young-Pil Kim DFI	Director of Finance/CFO	53	-
Ju-Sung Sim COO	Chief Operating Officer	57	-

Director	Title	Age	Since
Won-Soo Yoon BRD	Director/Board Member	56	-
Jin-Hyung Shin BRD	Director/Board Member	41	-
Song-Wan Jin BRD	Director/Board Member	51	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
3/6/25	Marinho Paulo Andre Nobrega	Others		3,392	0.0157%
3/6/25	Eun-kyung Cho	Others		15,492	0.0719%
2/26/25	Won-Soo Yoon	Buy	Chief Executive Officer	2,100	0.0097%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
T&R BIOFAB CO., LTD.	+3.09%	+1.42%	+11.54%	-75.44%	85.26M
STRYKER CORPORATION	-0.28%	-3.03%	-16.40%	+18.54%	126B
SMITH & NEPHEW PLC	+0.28%	+0.23%	-22.39%	-0.19%	12.24B
GLAUKOS CORPORATION	-0.45%	-4.74%	+92.53%	+144.41%	10.65B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+2.13%	-4.21%	-51.63%	-68.92%	4.21B
DOUBLE MEDICAL TECHNOLOGY INC.	+0.57%	+4.02%	-22.01%	+58.76%	2.77B
INSPIRE MEDICAL SYSTEMS, INC.	+1.20%	+0.18%	-32.64%	-71.33%	1.79B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	+1.12%	-0.84%	-23.32%	-12.99%	1.66B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	+0.47%	-3.59%	-36.96%	-38.68%	1.59B
Average	+0.90%	-0.05%	-11.26%	-5.09%	17.94B
Weighted average by Cap.	-0.13%	-2.62%	-11.12%	+21.90%

	2024	2025
Net sales	4.87B 3.52M 3.02M 2.83M 2.59M 4.88M 335M 4.9M 33.51M 12.99M 169M 13.2M 12.91M 560M	26.97B 19.45M 16.69M 15.67M 14.31M 27.01M 1.86B 27.14M 185M 71.86M 936M 73.03M 71.44M 3.1B
Net income	-7.68B -5.54M -4.75M -4.46M -4.07M -7.69M -528M -7.73M -52.8M -20.46M -266M -20.79M -20.34M -883M	-34.94B -25.2M -21.63M -20.3M -18.54M -35M -2.4B -35.17M -240M -93.12M -1.21B -94.63M -92.57M -4.02B
Net Debt	28.78B 20.76M 17.82M 16.72M 15.27M 28.82M 1.98B 28.96M 198M 76.69M 999M 77.94M 76.25M 3.31B	21.7B 15.65M 13.43M 12.61M 11.52M 21.73M 1.49B 21.84M 149M 57.83M 753M 58.77M 57.49M 2.49B